Science Explorer Back to mapMap
Discussion
Researcher · Shahid Beheshti University of Medical Sciences · Iran

Alireza Abadi

Alireza Abadi publishes mostly in Molecular Biology, Organic Chemistry and Oncology, on topics such as Synthesis and biological activity, Phosphodiesterase function and regulation and Global Cancer Incidence and Screening.

ORCID 0000-0002-7433-261X OpenAlex
World rank
#3,663,318
of 7,710,434 ranked researchers
Rank in Iran
#25,182
of 71,317
Works
396
Citations
5.3k
Citations per work
13.4
h-index
37
i10-index 134Top 8.9% in Molecular Biology
Alireza Abadi

What does Alireza Abadi research?

Alireza Abadi's work is mostly in Medicine (18%), Biochemistry, Genetics and Molecular Biology (14%), Chemistry (13%).

Everything else: 216 works · 54.5% of their workHealth Sciences: 71 works · 18.0% of their workMedicine: 71 works · 18.0% of their workOncology: 29 works · 7.4% of their workPharmacology: 17 works · 4.4% of their workPublic Health, Environmental and Occupational Health: 13 works · 3.2% of their workEpidemiology: 12 works · 3.0% of their workLife Sciences: 57 works · 14.3% of their workBiochemistry, Genetics and Molecular Biology: 57 works · 14.3% of their workMolecular Biology: 57 works · 14.3% of their workPhysical Sciences: 52 works · 13.2% of their workChemistry: 52 works · 13.2% of their workOrganic Chemistry: 52 works · 13.2% of their workTHEIR WORKAlireza Abadi396works
Life Sciences14%Physical Sciences13%Health Sciences18%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else21654.5%
    1. Medicine7118.0%
    1. Biochemistry, Genetics and Molecular Biology5714.3%
    1. Chemistry5213.2%
  1. 1Molecular Biology14% of their works
  2. 2Organic Chemistry13% of their works
  3. 3Oncology7% of their works
  4. 4Pharmacology4% of their works
  5. 5Public Health, Environmental and Occupational Health3% of their works
  6. 6Epidemiology3% of their works

Research topics

Which keywords describe Alireza Abadi's research?

The keywords of their largest research topics: Heterocyclic Compounds, Medicinal Chemistry, Tubulin Inhibitors, Vascular Targeting Agents, Synthesis, cAMP Signaling, Cyclic Nucleotide Phosphodiesterases and Cancer Incidence.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Heterocyclic Compounds562 topics
  2. Medicinal Chemistry562 topics
  3. Tubulin Inhibitors371 topic
  4. Vascular Targeting Agents371 topic
  5. Synthesis342 topics
  6. Cyclic Nucleotide Phosphodiesterases331 topic
  7. cAMP Signaling331 topic
  8. Cancer Incidence281 topic
  9. Mortality Rates281 topic
  10. Acetylcholinesterase191 topic
  11. Antimicrobial Activity191 topic
  12. Cholinesterase Inhibitors191 topic
  13. Quinoxaline191 topic
  14. DNA161 topic
  15. Topoisomerases161 topic
  16. Alkaloids151 topic
  17. Amaryllidaceae151 topic
  18. Mental Health151 topic
  19. Quality of Life151 topic

Where does Alireza Abadi work?

Alireza Abadi's main affiliation in the publication record is Shahid Beheshti University of Medical Sciences, Iran.

How many publications and citations does Alireza Abadi have?

OpenAlex counts 396 works and 5,302 citations for Alireza Abadi, an h-index of 37, ranking #3,663,318 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Alireza Abadi

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Alireza Abadi. Posts are plain text and can be reported.